GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...

Kirkland, Latham, Paul Weiss and others have replaced the likes of Sullivan & Cromwell, Clifford Chance and Slaughter and May ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

GSK has agreed to buy US biopharmaceutical business IDRx in a deal worth up to $1.15billion (£1billion). Under the agreement, GSK will pay $1billion upfront to acquire the Massachusetts-based ...

“Check out @flightriskmovie 兩 keeping it real兩 no bald cap兩兩 NO CAP ,” he captioned an Instagram Reels of him having his head shaved by a stylist. “F--- you lookin’ at?

In a surprising twist, the bumbling yet endearing Michael Scott of The Office may represent a dying breed in corporate America. As companies increasingly slash management roles, the era of hands ...

Partnerships in the biopharma industry have been a long-standing measure of research and development (R&D). Last month saw a number of alliances forming in a range of therapeutic spaces but there has ...